Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

Published:2012-08-15 Issue:19 Volume:18 Page:5399-5411
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Vidal August,Muñoz Clara,Guillén María-José,Moretó Jemina,Puertas Sara,Martínez-Iniesta María,Figueras Agnés,Padullés Laura,García-Rodriguez Francisco J.,Berdiel-Acer Mireia,Pujana Miguel A.,Salazar Ramón,Gil-Martin Marta,Martí Lola,Ponce Jordi,Molleví David G.,Capella Gabriel,Condom Enric,Viñals Francesc,Huertas Dori,Cuevas Carmen,Esteller Manel,Avilés Pablo,Villanueva Alberto

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and future perspectives of xenograft models of human ovarian cancer;Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks;2024

2. Patient-Derived Xenografts: Historical Evolution, Immunocompromised Host Models, and Translational Significance;Methods in Molecular Biology;2024

3. Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives;Environmental Toxicology and Pharmacology;2023-09

4. Recent advances in BCRP‐induced breast cancer resistance treatment with marine‐based natural products;IUBMB Life;2023-07-13

5. De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways;Clinical Cancer Research;2023-06-29